Cargando…

Detection of G338R FGFR2 mutation in a Vietnamese patient with Crouzon syndrome

Crouzon syndrome is a rare autosomal dominant genetic disorder, which causes the premature fusion of the cranial suture. Fibroblast growth factor receptor 2 (FGFR2) mutations are well-known causatives of Crouzon syndrome. The current study aimed to assess the FGFR2 gene associated with Crouzon syndr...

Descripción completa

Detalles Bibliográficos
Autores principales: Luong, Anh Lan Thi, Ho, Thuong Thi, Hoang, Ha, Nguyen, Trung Quang, Ho, Tu Cam, Tran, Phan Duc, Hoang, Thuy Thi, Nguyen, Nam Trung, Chu, Hoang Ha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350211/
https://www.ncbi.nlm.nih.gov/pubmed/30719288
http://dx.doi.org/10.3892/br.2019.1181
_version_ 1783390408028454912
author Luong, Anh Lan Thi
Ho, Thuong Thi
Hoang, Ha
Nguyen, Trung Quang
Ho, Tu Cam
Tran, Phan Duc
Hoang, Thuy Thi
Nguyen, Nam Trung
Chu, Hoang Ha
author_facet Luong, Anh Lan Thi
Ho, Thuong Thi
Hoang, Ha
Nguyen, Trung Quang
Ho, Tu Cam
Tran, Phan Duc
Hoang, Thuy Thi
Nguyen, Nam Trung
Chu, Hoang Ha
author_sort Luong, Anh Lan Thi
collection PubMed
description Crouzon syndrome is a rare autosomal dominant genetic disorder, which causes the premature fusion of the cranial suture. Fibroblast growth factor receptor 2 (FGFR2) mutations are well-known causatives of Crouzon syndrome. The current study aimed to assess the FGFR2 gene associated with Crouzon syndrome in a Vietnamese family of three generations and to characterize their associated clinical features. The family included in the present study underwent complete clinical examination. A patient was clinically examined and presented with typical features of Crouzon syndrome including craniosynostosis, shallow orbits, ocular proptosis and midface hypoplasia. However the patient had normal hands and feet, a normal hearing ability and normal intelligence. Genomic DNA collected from all family members (except from a 16 week-old-foetus) and 200 unrelated control subjects from the same population was extracted from leukocytes obtained from peripheral blood samples. Genomic DNA was extracted from the 16-week-old foetus via the amniotic fluid of the mother. All coding sequences of FGFR2 were amplified via polymerase chain reaction and directly sequenced. A heterozygous FGFR2 missense mutation (c.1012G>C, p.G338R) in exon 10 was identified in the patient with Crouzon but not in other family members, the 16 week-old-foetus or the controls. This mutation was therefore determined to be the causative agent of Crouzon syndrome. In addition, a novel heterozygous silent mutation (c.1164C>T, p.I388I) in exon 11 of the FGFR2 gene was identified in the patient with Crouzon, his mother and the 16-week-old fetus, but not in other family members. The mutation in exon 10 of FGRF2 was confirmed via restriction-enzyme digestion. The gain of the BsoBI site confirmed the FGFR2 mutation in exon 10 of the patient with Crouzon. This molecular finding may provide useful information to aid clinicians in the diagnosis of Crouzon syndrome and may also aid early prenatal diagnoses.
format Online
Article
Text
id pubmed-6350211
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-63502112019-02-04 Detection of G338R FGFR2 mutation in a Vietnamese patient with Crouzon syndrome Luong, Anh Lan Thi Ho, Thuong Thi Hoang, Ha Nguyen, Trung Quang Ho, Tu Cam Tran, Phan Duc Hoang, Thuy Thi Nguyen, Nam Trung Chu, Hoang Ha Biomed Rep Articles Crouzon syndrome is a rare autosomal dominant genetic disorder, which causes the premature fusion of the cranial suture. Fibroblast growth factor receptor 2 (FGFR2) mutations are well-known causatives of Crouzon syndrome. The current study aimed to assess the FGFR2 gene associated with Crouzon syndrome in a Vietnamese family of three generations and to characterize their associated clinical features. The family included in the present study underwent complete clinical examination. A patient was clinically examined and presented with typical features of Crouzon syndrome including craniosynostosis, shallow orbits, ocular proptosis and midface hypoplasia. However the patient had normal hands and feet, a normal hearing ability and normal intelligence. Genomic DNA collected from all family members (except from a 16 week-old-foetus) and 200 unrelated control subjects from the same population was extracted from leukocytes obtained from peripheral blood samples. Genomic DNA was extracted from the 16-week-old foetus via the amniotic fluid of the mother. All coding sequences of FGFR2 were amplified via polymerase chain reaction and directly sequenced. A heterozygous FGFR2 missense mutation (c.1012G>C, p.G338R) in exon 10 was identified in the patient with Crouzon but not in other family members, the 16 week-old-foetus or the controls. This mutation was therefore determined to be the causative agent of Crouzon syndrome. In addition, a novel heterozygous silent mutation (c.1164C>T, p.I388I) in exon 11 of the FGFR2 gene was identified in the patient with Crouzon, his mother and the 16-week-old fetus, but not in other family members. The mutation in exon 10 of FGRF2 was confirmed via restriction-enzyme digestion. The gain of the BsoBI site confirmed the FGFR2 mutation in exon 10 of the patient with Crouzon. This molecular finding may provide useful information to aid clinicians in the diagnosis of Crouzon syndrome and may also aid early prenatal diagnoses. D.A. Spandidos 2019-02 2019-01-03 /pmc/articles/PMC6350211/ /pubmed/30719288 http://dx.doi.org/10.3892/br.2019.1181 Text en Copyright: © Hoang Ha Chu et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Luong, Anh Lan Thi
Ho, Thuong Thi
Hoang, Ha
Nguyen, Trung Quang
Ho, Tu Cam
Tran, Phan Duc
Hoang, Thuy Thi
Nguyen, Nam Trung
Chu, Hoang Ha
Detection of G338R FGFR2 mutation in a Vietnamese patient with Crouzon syndrome
title Detection of G338R FGFR2 mutation in a Vietnamese patient with Crouzon syndrome
title_full Detection of G338R FGFR2 mutation in a Vietnamese patient with Crouzon syndrome
title_fullStr Detection of G338R FGFR2 mutation in a Vietnamese patient with Crouzon syndrome
title_full_unstemmed Detection of G338R FGFR2 mutation in a Vietnamese patient with Crouzon syndrome
title_short Detection of G338R FGFR2 mutation in a Vietnamese patient with Crouzon syndrome
title_sort detection of g338r fgfr2 mutation in a vietnamese patient with crouzon syndrome
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350211/
https://www.ncbi.nlm.nih.gov/pubmed/30719288
http://dx.doi.org/10.3892/br.2019.1181
work_keys_str_mv AT luonganhlanthi detectionofg338rfgfr2mutationinavietnamesepatientwithcrouzonsyndrome
AT hothuongthi detectionofg338rfgfr2mutationinavietnamesepatientwithcrouzonsyndrome
AT hoangha detectionofg338rfgfr2mutationinavietnamesepatientwithcrouzonsyndrome
AT nguyentrungquang detectionofg338rfgfr2mutationinavietnamesepatientwithcrouzonsyndrome
AT hotucam detectionofg338rfgfr2mutationinavietnamesepatientwithcrouzonsyndrome
AT tranphanduc detectionofg338rfgfr2mutationinavietnamesepatientwithcrouzonsyndrome
AT hoangthuythi detectionofg338rfgfr2mutationinavietnamesepatientwithcrouzonsyndrome
AT nguyennamtrung detectionofg338rfgfr2mutationinavietnamesepatientwithcrouzonsyndrome
AT chuhoangha detectionofg338rfgfr2mutationinavietnamesepatientwithcrouzonsyndrome